Emotional Intelligence and Chronic Orofacial Pain
IEDOF
2 other identifiers
observational
88
0 countries
N/A
Brief Summary
Chronic pain, lasting more than three months, is a widespread health issue that negatively impacts daily life, leading to significant emotional distress and functional impairment. Emotional intelligence, defined as the ability to recognize and manage one's own emotions as well as those of others, has been linked to better communication skills and reduced stress, which is a well-known risk factor for chronic pain. Studies have highlighted a correlation between emotional intelligence and certain chronic pain conditions, such as fibromyalgia and migraines. However, no research has yet explored its role in painful temporomandibular disorders (TMD). Given the strong involvement of psychosocial factors in TMD etiology, a better understanding of these elements could improve pain management and pave the way for preventive interventions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2026
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 1, 2025
CompletedFirst Posted
Study publicly available on registry
December 12, 2025
CompletedStudy Start
First participant enrolled
January 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2027
December 12, 2025
December 1, 2025
1 year
December 1, 2025
December 1, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Measurement of emotional intelligence score between both groups
Measurement of emotional intelligence score assessed by the TEIQue-SF questionnaire : The short version consists of 33 items assessing four factors: well-being, self-control, emotionality, and sociability. Each item is rated on a Likert scale ranging from 1 ("strongly disagree") to 7 ("strongly agree").
Day 0
Secondary Outcomes (5)
Measurement of anxiety disorders between both groups
Day 0
Measurement of the coping score between both groups
Day 0
Measurement of emotional regulation score between both groups
Day 0
Measurement of fatigue score between both groups
Day 0
Measurement of Depression disorders between both groups
Day 0
Study Arms (1)
Evaluation of the potential link between emotional intelligence and chronic orofacial pain.
All included subjects will have the same participation, which consists of completing several standardized questionnaires. These questionnaires assess various psychological and emotional aspects, including anxiety and depressive disorders (HADS questionnaire), coping strategies (Brief-COPE score), emotional regulation (ERS score), fatigue level (EVA scale), and emotional intelligence (TEIQue-SF questionnaire) to compare scores between the DTM group and the control group. Additionally, sociodemographic and psychosocial criteria will be collected to refine the analysis of the results. The completion of these questionnaires is part of routine consultations and does not alter the patients' standard care.
Interventions
All included subjects will be required to complete the following questionnaires: Hospital Anxiety and Depression Scale (HADS) Brief-COPE for coping assessment Emotion Reactivity Scale (ERS) for emotional regulation Visual Analog Scale (VAS) for fatigue assessment Sociodemographic and psychosocial evaluation Trait Emotional Intelligence Questionnaire - Short Form (TEIQue-SF) for emotional intelligence assessment
Eligibility Criteria
Regarding the evaluated population (cases), approximately 30 patients are seen each week in the oral health service for chronic orofacial pain consultations. About 60% of these patients have a diagnosis of painful TMD, which is around 18 patients per week. Including 44 patients in this study over a 6-month period thus seems feasible. Regarding the control population, more than 50 patients are seen daily in oral rehabilitation consultations at the oral health service of the CHU de Brest. These controls will be matched in gender and age (+/- 5 years) with the studied population (cases). The significant proportion of these patients should allow for the feasibility of this matching.
You may qualify if:
- For all subjects:
- Major subject
- Non-opposition obtained
- For subjects in the TMD group:
- Diagnosis of temporomandibular dysfunction -No other diagnosis of chronic pain
- For subjects in the control group:
- No diagnosis of chronic pain
- Subject not understanding French
- Subject under legal protection (guardianship or curatorship)
- Refusal to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 1, 2025
First Posted
December 12, 2025
Study Start
January 1, 2026
Primary Completion (Estimated)
January 1, 2027
Study Completion (Estimated)
January 1, 2027
Last Updated
December 12, 2025
Record last verified: 2025-12